Quick Takeaways
- PRICE T ROWE ASSOCIATES INC /MD/ filed SCHEDULE 13G/A for REPLIGEN CORP COMMON STOCK (RGEN).
- Disclosed ownership: 13%.
- Date of event: 31 Dec 2024.
PRICE T ROWE ASSOCIATES INC /MD/ - 31 Dec 2024 SCHEDULE 13G/A Report for REPLIGEN CORP COMMON STOCK (RGEN)
- Filing Manager
- PRICE T ROWE ASSOCIATES INC /MD/
- Reporting Manager
- T. Rowe Price Associates, Inc.
- Security
- REPLIGEN CORP COMMON STOCK
- Symbol
- RGEN
- Shares outstanding
- 56,189,654 shares
- Disclosed Ownership
- 7,136,086 shares
- Ownership
- 13%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Feb 2025, 09:44:09 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 08 Sep 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PRICE T ROWE ASSOCIATES INC /MD/ disclosed 13% ownership in REPLIGEN CORP COMMON STOCK (RGEN) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 Feb 2025, 09:44.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Associates, Inc. | 13% | 7,136,086 | 6,445,000 | 0 | Ellen York | Vice President |